Literature DB >> 25918919

Antibiotic prophylaxis for preventing meningitis in patients with basilar skull fractures.

Bernardo O Ratilal1, João Costa, Lia Pappamikail, Cristina Sampaio.   

Abstract

BACKGROUND: Basilar skull fractures predispose patients to meningitis because of the possible direct contact of bacteria in the paranasal sinuses, nasopharynx or middle ear with the central nervous system (CNS). Cerebrospinal fluid (CSF) leakage has been associated with a greater risk of contracting meningitis. Antibiotics are often given prophylactically, although their role in preventing bacterial meningitis has not been established.
OBJECTIVES: To evaluate the effectiveness of prophylactic antibiotics for preventing meningitis in patients with basilar skull fractures. SEARCH
METHODS: We searched CENTRAL (2014, Issue 5), MEDLINE (1966 to June week 1, 2014), EMBASE (1974 to June 2014) and LILACS (1982 to June 2014). We also performed an electronic search of meeting proceedings from the American Association of Neurological Surgeons (1997 to September 2005) and handsearched the abstracts of meeting proceedings of the European Association of Neurosurgical Societies (1995, 1999 and 2003). SELECTION CRITERIA: Randomised controlled trials (RCTs) comparing any antibiotic versus placebo or no intervention. We also identified non-RCTs to perform a separate meta-analysis in order to compare results. DATA COLLECTION AND ANALYSIS: Three review authors independently screened and selected trials, assessed risk of bias and extracted data. We sought clarification with trial authors when needed. We pooled risk ratios (RRs) for dichotomous data with their 95% confidence intervals (CIs) using a random-effects model. We assessed the overall quality of evidence using the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach. MAIN
RESULTS: In this update we did not identify any new trials for inclusion. We included five RCTs with 208 participants in the review and meta-analysis. We also identified 17 non-RCTs comparing different types of antibiotic prophylaxis with placebo or no intervention in patients with basilar skull fractures. Most trials presented insufficient methodological detail. All studies included meningitis in their primary outcome. When we evaluated the five included RCTs, there were no significant differences between antibiotic prophylaxis groups and control groups in terms of reduction of the frequency of meningitis, all-cause mortality, meningitis-related mortality and need for surgical correction in patients with CSF leakage. There were no reported adverse effects of antibiotic administration, although one of the five RCTs reported an induced change in the posterior nasopharyngeal flora towards potentially more pathogenic organisms resistant to the antibiotic regimen used in prophylaxis. We performed a subgroup analysis to evaluate the primary outcome in patients with and without CSF leakage. We also completed a meta-analysis of all the identified controlled non-RCTs (enrolling a total of 2168 patients), which produced results consistent with the randomised data from the included studies.Using the GRADE approach, we assessed the quality of trials as moderate. AUTHORS'
CONCLUSIONS: Currently available evidence from RCTs does not support prophylactic antibiotic use in patients with basilar skull fractures, whether there is evidence of CSF leakage or not. Until more research is available, the effectiveness of antibiotics in patients with basilar skull fractures cannot be determined because studies published to date are flawed by biases. Large, appropriately designed RCTs are needed.

Entities:  

Mesh:

Year:  2015        PMID: 25918919     DOI: 10.1002/14651858.CD004884.pub4

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  14 in total

Review 1.  [Complications of anterior skull base surgery].

Authors:  M Wagenmann; K Scheckenbach; B Kraus; I Stenin
Journal:  HNO       Date:  2018-06       Impact factor: 1.284

Review 2.  Recurrent Meningitis.

Authors:  Jon Rosenberg; Benjamin T Galen
Journal:  Curr Pain Headache Rep       Date:  2017-07

3.  Rapidly fatal pneumococcal meningitis following non-penetrating traumatic brain injury.

Authors:  Gustav Strandvik; Ahmed Shaaban; Abdelrahman Rawhi Mahmoud Alsaleh; Muhammad Mohsin Khan
Journal:  BMJ Case Rep       Date:  2020-02-17

4.  Decreased Incidence of CSF Leaks after Skull Base Fractures in the 21st Century: An Institutional Report.

Authors:  Brittany M Stopa; Oscar A Leyva; Cierra N Harper; Kyla A Truman; C Eduardo Corrales; Timothy R Smith; William B Gormley
Journal:  J Neurol Surg B Skull Base       Date:  2020-10-16

Review 5.  [Traumatology of the lateral skull base].

Authors:  Angelika Albrecht; Jörg Schipper
Journal:  HNO       Date:  2022-08-29       Impact factor: 1.330

6.  Recurrent meningitis in children: etiologies, outcome, and lessons to learn.

Authors:  Amira Masri; Abeer Alassaf; Najwa Khuri-Bulos; Imad Zaq; Azmy Hadidy; Faris G Bakri
Journal:  Childs Nerv Syst       Date:  2018-05-04       Impact factor: 1.475

7.  Contemporary Trends in the Management of Posttraumatic Cerebrospinal Fluid Leaks.

Authors:  Moustafa Mourad; Jared C Inman; David M Chan; Yadranko Ducic
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2016-11-01

8.  Surgical Outcomes and Postoperative Management in Spontaneous Cerebrospinal Fluid Rhinorrhea.

Authors:  Zi Yang Jiang; Caitlin McLean; Carlos Perez; Samuel Barnett; Deborah Friedman; Bobby A Tajudeen; Pete S Batra
Journal:  J Neurol Surg B Skull Base       Date:  2017-09-04

9.  Pneumocephalus as result of nonsurgical peri-implantitis treatment with an air-polishing device for submucosal debridement-A case report.

Authors:  Corinna Bruckmann; Lukas Bruckmann; André Gahleitner; Andreas Stavropoulos; Kristina Bertl
Journal:  Clin Exp Dent Res       Date:  2022-05-03

10.  Recurrent CSF Rhinorrhea Misdiagnosed as Chronic Allergic Rhinitis with Subsequent Development of Bacterial Meningitis.

Authors:  Michael T Ulrich; Lawrence K Loo; Michael B Ing
Journal:  Case Rep Med       Date:  2017-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.